INO

1.68

3.07% 0.05

Vorhandelsmarkt: 1.64 -0.04 -2.38%

Inovio Pharmaceuticals Inc (INO)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$1.63

Offen:

$1.65

24-Stunden-Volumen:

619.42K

Relative Volume:

0.46

Marktkapitalisierung:

$115.91M

Einnahmen:

$65,300

Nettoeinkommen (Verlust:

$-84.95M

KGV:

-0.869

EPS:

-1.9332

Netto-Cashflow:

$-88.92M

1W Leistung:

-2.89%

1M Leistung:

+3.07%

6M Leistung:

-22.94%

1J Leistung:

-20.38%

1-Tages-Spanne:

$1.63

$1.72

1-Wochen-Bereich:

$1.59

$1.78

52-Wochen-Spanne:

$1.30

$2.9789

Inovio Pharmaceuticals Inc Stock (INO) Company Profile

Firmenname

Inovio Pharmaceuticals Inc

Sektor

Healthcare (1114)

Branche

Biotechnology (620)

Telefon

(858) 410-3134

Adresse

660 W. GERMANTOWN PIKE, PLYMOUTH MEETING, PA

Mitarbeiter

134

Twitter

@inoviopharma

Nächster Verdiensttermin

2026-03-12

Neueste SEC-Einreichungen

INO's Discussions on Twitter

Compare INO vs VRTX, REGN, ARGX, ALNY, ONC

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
INO Inovio Pharmaceuticals Inc	1.68	112.46M	65,300	-84.95M	-88.92M	-1.9332
VRTX Vertex Pharmaceuticals Inc	462.49	118.41B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	759.05	80.02B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	706.03	43.52B	4.16B	1.29B	734.26M	19.59
ALNY Alnylam Pharmaceuticals Inc	320.42	42.29B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	287.33	32.13B	5.36B	287.73M	924.18M	2.5229

Inovio Pharmaceuticals Inc Stock (INO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-07-09	Eingeleitet	Piper Sandler	Overweight
2024-05-14	Eingeleitet	Stephens	Overweight
2024-01-25	Hochstufung	Oppenheimer	Perform → Outperform
2022-11-09	Herabstufung	Maxim Group	Buy → Hold
2022-11-01	Herabstufung	BofA Securities	Neutral → Underperform
2022-07-19	Fortgesetzt	RBC Capital Mkts	Sector Perform
2022-05-11	Herabstufung	Oppenheimer	Outperform → Perform
2022-01-21	Hochstufung	BofA Securities	Underperform → Neutral
2021-12-29	Fortgesetzt	Jefferies	Hold
2021-09-10	Herabstufung	BofA Securities	Neutral → Underperform
2021-06-24	Eingeleitet	Jefferies	Hold
2021-03-23	Eingeleitet	BofA Securities	Neutral
2021-02-12	Eingeleitet	Oppenheimer	Outperform
2020-11-17	Herabstufung	ROTH Capital	Neutral → Sell
2020-11-10	Hochstufung	ROTH Capital	Sell → Neutral
2020-09-28	Herabstufung	Cantor Fitzgerald	Overweight → Neutral
2020-09-28	Hochstufung	Maxim Group	Hold → Buy
2020-07-01	Herabstufung	Maxim Group	Buy → Hold
2020-07-01	Herabstufung	ROTH Capital	Neutral → Sell
2020-06-29	Herabstufung	H.C. Wainwright	Buy → Neutral
2020-06-26	Herabstufung	Stifel	Buy → Hold
2020-05-21	Eingeleitet	The Benchmark Company	Buy
2020-04-30	Herabstufung	ROTH Capital	Buy → Neutral
2020-03-13	Herabstufung	Piper Sandler	Overweight → Neutral
2020-03-13	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2019-12-19	Eingeleitet	ROTH Capital	Buy
2018-02-15	Bestätigt	Maxim Group	Buy
2017-10-18	Eingeleitet	RBC Capital Mkts	Outperform
2017-09-06	Eingeleitet	Citigroup	Buy
2017-06-08	Hochstufung	Piper Jaffray	Neutral → Overweight
2017-05-24	Bestätigt	Maxim Group	Buy
2017-03-16	Hochstufung	Maxim Group	Hold → Buy
2017-03-16	Herabstufung	Piper Jaffray	Overweight → Neutral

Alle ansehen

Inovio Pharmaceuticals Inc Aktie (INO) Neueste Nachrichten

Mar 17, 2026

INOVIO to Present DNA Medicine Data at Two Scientific Conferences - MyChesCo

Mar 17, 2026

Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch

Mar 17, 2026

Inovio (INO) Q4 2025 Earnings Call Transcript - The Globe and Mail

Mar 17, 2026

INO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026 (2026-03-17) - Seeking Alpha

Mar 17, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Richtech Robotics Inc. of Class Action Lawsuit and Upcoming Deadlines – RR - GlobeNewswire Inc.

Mar 17, 2026

Holzer & Holzer, LLC Reminds Investors of April 7, 2026 - GlobeNewswire

Mar 17, 2026

DEADLINE ALERT for TCPC, ORCL, PSFE, and INO: The Law - GlobeNewswire

Mar 17, 2026

INO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Inovio Pharmaceuticals, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Mar 17, 2026

INO Shareholder Alert: April 7, 2026 Lead Plaintiff Deadline in Inovio Pharmaceuticals, Inc. Securities Class Action Lawsuit -- The Gross Law Firm - PR Newswire

Mar 17, 2026

Mar 16, 2026

Inovio Pharmaceuticals Inc. stock underperforms Monday when compared to competitors - MarketWatch

Mar 16, 2026